These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20576050)

  • 1. Increase of B-type natriuretic peptide from baseline increases the risk of death or retransplant in pediatric cardiac transplant patients, midterm results.
    Bramlet M; Moore R; Murphy D; Caldwell R; Darragh R; Schamberger M
    Congenit Heart Dis; 2010; 5(3):297-302. PubMed ID: 20576050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
    Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
    Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of brain natriuretic peptide in heart transplant patients.
    Martinez-Dolz L; Almenar L; Moro J; Agüero J; Hervas I; Rueda J; Rivera M; Arnau MA; Mateo A; Salvador A
    J Heart Lung Transplant; 2007 Oct; 26(10):986-91. PubMed ID: 17919617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relationship between two serial determinations of B-type natriuretic peptide and medium-long-term events in heart transplantation.
    Martínez-Dolz L; Almenar L; Hervás I; Moro J; Agüero J; Sánchez-Lázaro I; Mateo A; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):735-40. PubMed ID: 18582802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients.
    Singh TP; Edwards LB; Kirk R; Boucek MM
    J Heart Lung Transplant; 2009 Dec; 28(12):1285-91. PubMed ID: 19782597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients.
    Breidthardt T; Kalbermatter S; Socrates T; Noveanu M; Klima T; Mebazaa A; Mueller C; Kiss D
    Eur J Heart Fail; 2011 Aug; 13(8):860-7. PubMed ID: 21628312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
    Pimenta J; Paulo C; Gomes A; Silva S; Rocha-Gonçalves F; Bettencourt P
    Liver Int; 2010 Aug; 30(7):1059-66. PubMed ID: 20492497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide: perioperative patterns in congenital heart disease.
    Niedner MF; Foley JL; Riffenburgh RH; Bichell DP; Peterson BM; Rodarte A
    Congenit Heart Dis; 2010; 5(3):243-55. PubMed ID: 20576043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.
    Law YM; Hoyer AW; Reller MD; Silberbach M
    J Am Coll Cardiol; 2009 Oct; 54(15):1467-75. PubMed ID: 19796740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
    Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.
    Lindblade CL; Chun DS; Darragh RK; Caldwell RL; Murphy DJ; Schamberger MS
    Am J Cardiol; 2005 Apr; 95(7):909-11. PubMed ID: 15781032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients.
    Rossano JW; Denfield SW; Kim JJ; Price JF; Jefferies JL; Decker JA; Smith EO; Clunie SK; Towbin JA; Dreyer WJ
    J Heart Lung Transplant; 2008 Jun; 27(6):649-54. PubMed ID: 18503965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
    Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.